WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

DDD alterations

ATC codeATC level name Previous DDDNew DDDDeadline for objection to temporary codesImplementation in ATC/DDD index
L04AJ02ravulizumab58.9 mg P 70 mg P01.09.20242025
L02BA03fulvestrant 8.3 mg P 16.7 mg P01.09.20242025
L01EX15pexidartinib0.8 g O 0.5 g O01.09.20242025
L01EX08lenvatinib18 mg O 20 mg O01.09.20242025
J05AB16remdesivir0.1 g P 0.12 g P01.09.20242025
C03DA01spironolactone 75 mg O37.5 mg OFinal2025

Last updated: 2024-05-07